Bimode-M 2.5mg/500mg Tablet
By Bimode-M
Rx
10 Tablet in a Strip

Composition
Glipizide(2.5mg) + Metformin(500mg)

Manufacturer - Nucron Pharmaceuticals Pvt Ltd
c-7-b(2), industrial estatebhosari, pune-411026. mh 000000 in

Expires on or after
October, 2025

liver
Bimode-M 2.5mg/500mg Tablet requires caution in patients with liver disease. It may be necessary to adjust the dose of Bimode-M 2.5mg/500mg Tablet, so it's crucial to seek advice from your doctor. Typically, Bimode-M 2.5mg/500mg Tablet is initiated at a low dose for individuals with mild to moderate liver disease. However, it is advisable not to use this medication in patients with severe liver disease.

kidney
Bimode-M 2.5mg/500mg Tablet requires caution if you have kidney disease. Adjustments to the dose may be necessary, so always speak to your doctor. Avoid the use of Bimode-M in severe kidney disease. Regular kidney function tests are recommended during the treatment.

alcohol
It is not safe to drink alcohol while taking Bimode-M 2.5mg/500mg Tablet.

driving
When taking Bimode-M 2.5mg/500mg Tablet, avoid driving if you experience low or high blood sugar symptoms that may affect your ability to drive safely. It is important to prioritize safety on the roads to prevent any potential risks.

pregnancy
Bimode-M 2.5mg/500mg Tablet may be harmful during pregnancy. Animal studies indicate potential risks to the developing baby. Your doctor will assess the benefits and risks before prescribing. Kindly consult your doctor regarding this matter.

breastfeeding
Bimode-M 2.5mg/500mg Tablet may not be safe to use while breastfeeding. Limited human data indicates that the medication might enter breastmilk and pose a risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹12
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025